Abstract
Purpose
To assess the safety and efficacy of intracorneal ring segment (Intacs ring) implantation in managing keratoconus.
Methods
This retrospective case series comprised of 11 keratoconic eyes (11 patients) had Intacs ring (Addition Technology, Inc, California, USA) implantation. The main outcome measures were best corrected visual acuity, refraction, keratometry, topography, and pachymetry. Patients were examined before Intacs ring implantation as well as one week, one, three, and six months postoperatively.
Results
The mean best corrected visual acuity improved from 0.60±0.33 logMAR preoperatively to 0.39±0.23 logMAR six months postoperatively (p >0.05) and the mean corneal thickness, from 432.82±41.17 μm preoperatively to 448.00±62.27 μm at six months (p >0.05). The mean cylinder improved from -5.36±2.70D preoperatively to -2.50±1.66D six months postoperatively (p <0.05) and the mean keratometry, from 47.99±2.38D to 42.83±1.72D at six months (p <0.05). In addition, the mean spherical equivalent improved from -6.64±3.49D preoperatively to -3.66±3.37D six months postoperatively (p <0.05). One eye had a risk of ring exposure, but the others had no significant complications.
References
1. Rathi VM, Krishnamachary M, Gupta S. Cataract formation after penetrating keratoplasty. J Cataract Refract Surg. 1997; 23:562–4.
2. Ing JJ, Ing HH, Nelson LR, et al. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology. 1998; 105:1855–65.
3. Colin J, Cochener B, Savary G, Malet F. Correcting keratoconus with intracorneal rings. J Cataract Refract Surg. 2000; 26:1117–22.
4. Siganos CS, Kymionis GD, Kartakis N, et al. Management of keratoconus with Intacs. Am J Ophthalmol. 2003; 135:64–70.
5. Hellstedt T, Makela J, Uusitalo R, et al. Treating keratoconus with intacs corneal ring segments. J Refract Surg. 2005; 21:236–46.
6. Meek KM, Tuft SJ, Huang Y, et al. Changes in collagen orientation and distribution in keratoconus corneas. Invest Ophthalmol Vis Sci. 2005; 46:1948–56.
7. Troutman RC, Gaster RN. Surgical advances and results of keratoconus. Am J Ophthalmol. 1980; 90:131–6.
8. Frost NA, Wu J, Lai TF, Coster DJ. A review of randomized controlled trials of penetrating keratoplasty techniques. Ophthalmology. 2006; 113:942–9.
9. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135:620–7.
10. Alio JL, Shabayek MH, Belda JI, et al. Analysis of results related to good and bad outcomes of Intacs implantation for keratoconus correction. J Cataract Refract Surg. 2006; 32:756–61.
11. Guell JL. Are intracorneal rings still useful in refractive surgery? Curr Opin Ophthalmol. 2005; 16:260–5.
12. Sharma M, Boxer Wachler BS. Comparison of single-segment and double-segment Intacs for keratoconus and post-LASIK ectasia. Am J Ophthalmol. 2006; 141:891–5.
13. Chan SM, Khan HN. Reversibility and exchangeability of intrastromal corneal ring segments. J Cataract Refract Surg. 2002; 28:676–81.
14. Zare MA, Hashemi H, Salari MR. Intracorneal ring segment implantation for the management of keratoconus: safety and efficacy. J Cataract Refract Surg. 2007; 33:1886–91.
16. Ratkay-Traub I, Ferincz IE, Juhasz T, et al. First clinical results with the femtosecond neodynium-glass laser in refractive surgery. J Refract Surg. 2003; 19:94–103.
17. Coskunseven E, Kymionis GD, Tsiklis NS, et al. One-year results of intrastromal corneal ring segment implantation (KeraRing) using femtosecond laser in patients with keratoconus. Am J Ophthalmol. 2008; 145:775–9.
18. Kymionis GD, Siganos CS, Tsiklis NS, et al. Long-term follow-up of Intacs in keratoconus. Am J Ophthalmol. 2007; 143:236–44.
Table 1.
Table 2.
Parameter |
Mean± SD |
||||
---|---|---|---|---|---|
Preoperative | 1 week | 1 month | 3 months | 6 months | |
BCVA* (logMAR) | 0.60±0.33 | 0.53±0.29 | 0.50±0.20 | 0.45±0.32 | 0.39±0.23 |
Cylinder (D) | -5.36±2.70 | -3.14±2.29 | -4.09±3.83 | -3.50±1.58 | -2.50±1.66§ |
Spherical equivalent (D) | -6.64±3.49 | -2.43±3.78‡ | -4.91±5.21 | -5.38±3.68 | -3.66±3.37§ |
Mean keratometry (D) | 47.99±2.38 | 41.36±2.90‡ | 42.98±2.81‡ | 42.99±2.89§ | 42.83±1.72‡ |
Pachymetry† (µm) | 432.82±41.17 | 448.18±58.07 | 435.64±53.51 | 431.27±47.30 | 448.00±62.27 |
Table 3.
Case No. |
PreOP |
PostOP 6 months |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | Sex | BCVA*(logMAR) | SE†(D) | Cylinder (D) | Mean K‡(D) | Pachymetry§(µm) | BCVA*(logMAR) | ) SE†(D) | Cylinder (D) | Mean K‡(D) | Pachymetry§(μm) | |
1 | 31 | M | 1.00 | -7.50 | -5.00 | 49.40 | 408 | 0.15 | -7.00 | -4.00 | 43.80 | 554 |
2 | 32 | M | 1.00 | -6.00 | -4.00 | 45.00 | 442 | 0.22 | -0.75 | -1.50 | 40.00 | 421 |
3 | 32 | M | 0.40 | -8.50 | -4.00 | 48.70 | 368 | 0.52 | -9.50 | -1.00 | 44.60 | 378 |
4 | 31 | F | 0.52 | -8.00 | 0.00 | 49.50 | 457 | 0.70 | -6.75 | -4.50 | 41.50 | 420 |
5 | 29 | M | 0.40 | -4.50 | -9.00 | 45.00 | 449 | 0.10 | -0.50 | -3.00 | 42.50 | 468 |
6 | 31 | M | 0.40 | 0.00 | -6.00 | 47.80 | 506 | 0.70 | -0.88 | -1.75 | 45.60 | 517 |
7 | 29 | M | 0.10 | -4.00 | -5.00 | 43.60 | 478 | 0.05 | 0.50 | -2.00 | 40.70 | 514 |
8 | 31 | M | 0.40 | -3.25 | -3.50 | 49.30 | 448 | 0.52 | -1.13 | -1.25 | 42.90 | 468 |
9 | 31 | F | 1.00 | -8.50 | -5.00 | 50.40 | 399 | 0.52 | -4.50 | -3.00 | 44.30 | 432 |
10 | 20 | M | 0.40 | -11.50 | -9.00 | 48.60 | 385 | 0.40 | -3.25 | -5.50 | 43.30 | 354 |
11 | 32 | F | 1.00 | -11.25 | -8.50 | 50.60 | 421 | 0.40 | -6.50 | 0.00 | 41.90 | 402 |
Table 4.
Preoperative Keratometry (D) |
Mean BCVA* (logMAR)± SD |
Mean SE†± SD |
Mean Cylinder± SD |
|||
---|---|---|---|---|---|---|
PreOP | 6-Month PostOP | PreOP | 6-Month PostOP | PreOP | 6-Month PostOP | |
<49 (6 eyes) | 0.45±0.29 | 0.33±0.25 | -5.75±3.96 | -2.40±3.69 | -6.17±2.32 | -2.46±1.63‡ |
≥49 (5 eyes) | 0.78±0.30 | 0.46±0.20 | -7.70±2.88 | -5.18±2.47§ | -4.40±3.07 | -2.55±1.89 |